Pharmacogenetic clinical randomised phase II trial to...

  • Main
  • 2018 / 12
  • Pharmacogenetic clinical randomised phase II trial to...

Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype

Páez, David, Tobeña, María, Fernández-Plana, Julen, Sebio, Ana, Virgili, Anna C., Cirera, Lluís, Barnadas, Agustí, Riera, Pau, Sullivan, Ivana, Salazar, Juliana
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/s41416-018-0348-7
Date:
December, 2018
File:
PDF, 315 KB
english, 2018
Conversion to is in progress
Conversion to is failed